u 74500a has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levitt, MA; Sievers, RE; Wolfe, CL | 1 |
| Kawachi, Y; Masuda, M; Miyamoto, K; Morita, S; Nishida, T; Tominaga, R; Yasui, H | 1 |
2 other study(ies) available for u 74500a and Myocardial Ischemia
| Article | Year |
|---|---|
Reduction of infarct size during myocardial ischemia and reperfusion by lazaroid U-74500A, a nonglucocorticoid 21-aminosteroid.
Topics: Animals; Disease Models, Animal; Heart; Hemodynamics; Lipid Peroxides; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Pregnatrienes; Rats | 1994 |
Lazaroid (U74500A) prevents vascular and myocardial dysfunction after 24-hour heart preservation. A study based on cross-circulated blood-perfused rabbit hearts.
Topics: Animals; Antioxidants; Coronary Vessels; Endothelium, Vascular; Lipid Peroxidation; Myocardial Ischemia; Organ Preservation; Perfusion; Pregnatrienes; Rabbits; Vasodilation; Ventricular Dysfunction | 1996 |